Jin Medical(ZJYL.US)

Company Encyclopedia
View More
name
Jin Medical
ZJYL.US
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. It operates in China, Japan, the United States, Hong Kong, Singapore, Korea, Australia, and internationally.
1.378 T
ZJYL.USMarket value -Rank by Market Cap -/-

Financial Score

02/01/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking41/175
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE6.62%C
    • Profit Margin7.85%B
    • Gross Margin25.63%C
  • Growth ScoreB
    • Revenue YoY13.42%B
    • Net Profit YoY-38.31%D
    • Total Assets YoY17.89%A
    • Net Assets YoY6.12%B
  • Cash ScoreB
    • Cash Flow Margin1273.22%B
    • OCF YoY13.42%B
  • Operating ScoreC
    • Turnover0.51C
  • Debt ScoreC
    • Gearing Ratio42.80%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Some Jin Medical International Ltd. (NASDAQ:ZJYL) Shareholders Look For Exit As Shares Take 27% Pounding

    Jin Medical International Ltd. (NASDAQ:ZJYL) shares have dropped 27% in the last month, continuing a year-long decline of 74%. Despite a high P/E ratio of 21.8x, the company's earnings have been declining, raising concerns about future share price stability. Investors remain bullish, but the high P/E suggests potential risks if earnings trends continue. Shareholders should consider the risks and explore other investment options.

    Simplywall·
    US
    ZJYL
    +2.32%
    Simplywall·
    US
    ZJYL
    +2.32%

    Jin Medical International (NASDAQ:ZJYL) Stock Price Down 8.8% on Analyst Downgrade

    Jin Medical International (NASDAQ:ZJYL) shares fell 8.8% to $0.31 following a downgrade by Weiss Ratings from hold (c-) to sell (d+). The trading volume decreased by 14% compared to the average, with 219,992 shares exchanged. The company's 50-day and 200-day moving averages are $0.56 and $0.67, respectively. Jin Medical specializes in products for individuals with disabilities, including wheelchairs and oxygen concentrators. Despite the downgrade, analysts suggest other stocks may be better investment options.

    Market Beat·
    US
    ZJYL
    +2.32%
    Market Beat·
    US
    ZJYL
    +2.32%

    Some Jin Medical International Ltd. (NASDAQ:ZJYL) Shareholders Look For Exit As Shares Take 33% Pounding

    Jin Medical International Ltd. (NASDAQ:ZJYL) shares have plummeted 33% over the past month, resulting in an 83% loss for shareholders over the last year. Despite this decline, the company's P/E ratio remains high at 38x, indicating investor optimism. However, with a 39% decrease in earnings and a 99% drop in EPS over three years, concerns grow about the sustainability of this valuation. Analysts warn that if earnings continue to decline, the share price may fall further, posing risks for current and potential investors.

    Simplywall·
    US
    ZJYL
    +2.32%
    Simplywall·
    US
    ZJYL
    +2.32%

    12 Health Care Stocks Moving In Tuesday's After-Market Session

    In Tuesday's after-market session, several health care stocks saw significant movements. Revelation Biosciences (REVB) gained 7.7% to $2.51, with a market value of $4.7 million. Nautilus Biotechnology (NAUT) rose 7.47% to $0.72, valued at $88.0 million. Ernexa Therapeutics (ERNA) increased 7.37% to $1.36, with a market cap of $9.1 million. Kura Oncology (KURA) saw a 6.99% rise to $8.57, valued at $706.5 million. Jin Medical International (ZJYL) rose 5.95% to $0.68, with a market value of $98.6 million, and TNF Pharmaceuticals (TNFA) increased 5.88% to $3.78, valued at $6.7 million.

    Benzinga·
    US
    KURA
    -0.53%
    Benzinga·
    US
    KURA
    -0.53%

    Jin Medical International (NASDAQ:ZJYL) Shares Up 26.8% - What's Next?

    Jin Medical International (NASDAQ:ZJYL) shares surged 26.8% to $0.72, with trading volume increasing by 289% compared to the average. The company specializes in manufacturing wheelchairs and living aids for individuals with disabilities. Despite the stock's recent performance, analysts maintain a Hold rating, suggesting that there are better investment options available. Jin Medical's 50-day and 200-day moving averages are $0.64 and $0.74, respectively.

    Market Beat·
    US
    ZJYL
    +2.32%
    Market Beat·
    US
    ZJYL
    +2.32%
    © 2026 Longbridge｜Disclaimer